Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsJeanne Hendrickson, MD
Professor AdjunctDownloadHi-Res Photo
About
Copy Link
Titles
Professor Adjunct
Biography
Dr. Hendrickson is a pediatric hematologist and transfusion medicine specialist. Her clinical interests include factors influencing alloimmunization (particularly red blood cell alloimmunization), as well as strategies to minimize the formation and dangers of such antibodies. Her translational research interests include investigating the induction and consequences of red blood cell alloantibodies in transfusion and pregnancy situations, in murine models and in the clinical setting.
Last Updated on April 07, 2025.
Appointments
Laboratory Medicine
Professor AdjunctPrimary
Other Departments & Organizations
- All Institutions
- Blood Bank
- Cancer Immunology
- Laboratory Medicine
- Yale Center for Immuno-Oncology
- YCCEH
Education & Training
- Fellowship
- Emory School of Medicine (2008)
- Fellowship
- Emory University School of Medicine (2007)
- Residency
- Emory University School of Medicine (2002)
- MD
- Emory University School of Medicine (1999)
- BS
- University of North Carolina @ Chapel Hill (1994)
Research
Copy Link
Overview
Please pubmed search Hendrickson JE to see the range of topics the Hendrickson lab is interested in. In general, the lab is interested in investigating clinically relevant issues in transfusion medicine using basic science models and translational research tools.
Cellular therapy; Red blood cell alloimmunization
Medical Research Interests
Anemia, Sickle Cell; Blood Transfusion; Hematology; Immune Tolerance; Immunity, Humoral; Plasmapheresis; Pregnancy Complications, Hematologic; Transfusion Medicine
ORCID
0000-0002-7928-3132
Research at a Glance
Yale Co-Authors
Frequent collaborators of Jeanne Hendrickson's published research.
Publications Timeline
A big-picture view of Jeanne Hendrickson's research output by year.
Research Interests
Research topics Jeanne Hendrickson is interested in exploring.
Christopher Tormey, MD
Ronald George Hauser III, MD
Oliver Karam, MD, PhD
Alexa Siddon, MD
Alfred Lee, MD, PhD
John D Roberts, MD
149Publications
1,095Citations
Blood Transfusion
Anemia, Sickle Cell
Hematology
Immune Tolerance
Publications
2026
RhD variants: Detected despite 3+ testing in gel
Lever A, Pineda O, Muhammad S, Arteaga‐Cortes L, Marke A, Dent E, Hendrickson J. RhD variants: Detected despite 3+ testing in gel. Transfusion 2026 PMID: 41708561, DOI: 10.1111/trf.70135.Peer-Reviewed Original ResearchDelayed hemolytic transfusion reaction due to anti‐Jka with agglutination on blood smear
Cappello E, Archer L, Aurora T, Sikora J, Hendrickson J. Delayed hemolytic transfusion reaction due to anti‐Jka with agglutination on blood smear. Transfusion 2026 PMID: 41665117, DOI: 10.1111/trf.70128.Peer-Reviewed Original ResearchRBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report
Inam Z, Stenger E, John T, Liu K, Gillespie S, Shah R, Chellapandian D, Bhatia M, Chaudhury S, Eckrich M, Guilcher G, Hendrickson J, Hulbert M, Jaroscak J, Kasow K, Camacho‐Bydume C, Ngwube A, Olson T, Rangarajan H, Horan J, Krishnamurti L, Shenoy S, Abraham A, Nickel R. RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report. American Journal Of Hematology 2026, 101: 756-767. PMID: 41524608, DOI: 10.1002/ajh.70200.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsGrade III-IV acute graft-versus-host diseaseRed blood cell alloimmunizationHematopoietic cell transplantationSickle cell diseaseRed blood cellsTransfusion burdenRBC alloimmunizationPlatelet transfusionsAcute GVHDIII-IV acute graft-versus-host diseaseIncidence of grade III-IV acute graft-versus-host diseaseAcute graft-versus-host diseaseGraft-versus-host diseaseDonor hematopoietic cell transplantationRed blood cell unitsNon-alloimmunized patientsPost-HCT outcomesRBC transfusion burdenImmune-mediated complicationsRejection-free survivalPost-HCT patientsAlloimmunized groupGVHD-freeAlloimmunized patientsRetrospective registryNeonatal outcomes following maternal red cell transfusions prior to or at delivery
Mast A, Baumann Kreuziger L, Custer B, Vichinsky E, Hendrickson J, Spencer B, Hod E, Sachais B, Chapman K, Rowley E, Luban N, Norris P, Stone M, Ness P, Josephson C, Kleinman S, Tamburro R, Frank D, Hailu B, Malkin K. Neonatal outcomes following maternal red cell transfusions prior to or at delivery. Journal Of Perinatology 2026, 1-3. PMID: 41526680, DOI: 10.1038/s41372-025-02553-1.Peer-Reviewed Original ResearchAltmetric
2025
International classification of diseases codes have low positive predictive value for neonatal morbidities
Hendrickson J, Birch R, Sola-Visner M, Branchford B, Chen X, Custer B, Desimone R, Bougie D, Edwards E, Goel R, Gottschall J, Hod E, Moayeri M, Roubinian N, Karam O, Stone E, Luban N, Josephson C, Patel R. International classification of diseases codes have low positive predictive value for neonatal morbidities. Journal Of Perinatology 2025, 1-2. PMID: 41310310, PMCID: PMC12716811, DOI: 10.1038/s41372-025-02470-3.Peer-Reviewed Original ResearchAltmetric49 Supporting ABO Incompatible transplantation: Validating Dithiothreitol Anti-A Titers
Bhushan M, Arteaga-Cortes L, Hendrickson J, Badell R, Bingaman A, Murphey C, Sullivan H. 49 Supporting ABO Incompatible transplantation: Validating Dithiothreitol Anti-A Titers. American Journal Of Clinical Pathology 2025, 164: aqaf121.476. DOI: 10.1093/ajcp/aqaf121.476.Peer-Reviewed Original ResearchConceptsAnti-A titersA1 red cellsTube titrationABO-incompatible transplantationRed cellsTiter plasmaIncompatible transplantationTiter cutoffTransplantationTransplant centersAntibody titersLow titersTransplant programsRecipient eligibilityTiter methodBlood banksTitersTreated serumB transplantsEligibilitySerumAHGComparing labTransplantation NetworkEligibility statusTemporal Trends in Red Blood Cell and Platelet Transfusion Thresholds for Extremely Low Birth Weight Infants
Patel R, Hendrickson J, Birch R, Bougie D, Branchford B, Chen X, Custer B, Desimone R, Edwards E, Goel R, Gottschall J, Hod E, Moayeri M, Karam O, Stone E, Luban N, Josephson C, Sola-Visner M, Study-IV-Pediatric N. Temporal Trends in Red Blood Cell and Platelet Transfusion Thresholds for Extremely Low Birth Weight Infants. The Journal Of Pediatrics 2025, 288: 114797. PMID: 40887015, PMCID: PMC12533266, DOI: 10.1016/j.jpeds.2025.114797.Peer-Reviewed Original ResearchCitationsAltmetricConceptsPretransfusion platelet countPretransfusion hemoglobinPlatelet countRed blood cellsPlatelet transfusionsPostnatal weekELBW infantsTransfusion thresholdsExtremely low birth weight infantsLow birth weight infantsRed blood cell transfusion thresholdsRed blood cell transfusionBirth weight infantsPlatelet transfusion thresholdsBlood cellsPretransfusion hemoglobin valuesWeight infantsMulticenter cohortRecipient EpidemiologyUS CentersPretransfusionRandomized trialsTransfusionHemoglobin valuesInfantsA Single‐Center Retrospective Study Evaluating the Role of Therapeutic Plasma Exchange in Patients With an Initial Diagnosis of Optic Neuritis
Bhushan M, Schneider T, Hendrickson J. A Single‐Center Retrospective Study Evaluating the Role of Therapeutic Plasma Exchange in Patients With an Initial Diagnosis of Optic Neuritis. Journal Of Clinical Apheresis 2025, 40: e70052. PMID: 40838386, DOI: 10.1002/jca.70052.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsTherapeutic plasma exchangeOptic neuritisPlasma exchangeInitiation of therapeutic plasma exchangeDuration of visual symptomsMyelin oligodendrocyte glycoprotein antibody-associated diseaseTPE courseDiagnosis of optic neuritisSingle-center retrospective studyNeuromyelitis optica spectrum disorderTherapeutic plasma exchange treatmentHigh-dose steroidsAntibody-associated diseaseModerate clinical improvementOutcomes of patientsDiagnosis of ONAverage durationLong durationApheresis servicesClinical improvementRetrospective studyDetect antibodiesPresence of detectable antibodiesPatientsMedical recordsReport of the ASFA Apheresis Registry Study on Focal Segmental Glomerulosclerosis
Srivaths P, Monis G, Fernando L, Hendrickson J, Raval J, Jacquot C, Davis K, Wong E, Yamada C. Report of the ASFA Apheresis Registry Study on Focal Segmental Glomerulosclerosis. Journal Of Clinical Apheresis 2025, 40: e70041. PMID: 40641429, DOI: 10.1002/jca.70041.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsTherapeutic plasma exchangeFocal segmental glomerulosclerosisPost-transplant recurrencePlasma volume exchangesReplacement fluidSegmental glomerulosclerosisMedian urine protein/creatinine ratioPost-transplant focal segmental glomerulosclerosisDiagnosis of focal segmental glomerulosclerosisOutcomes of patientsEnd-stage kidney diseaseUrine protein/creatinine ratioComplete/partial remissionPlasma exchangeClinical courseComplication rateMedian ageProtein/creatinine ratioStandard treatmentCitrate anticoagulationRegistry studyKidney diseasePatientsMonthsTransplantationAnti‐Fy3 in one hospital system: More common than expected
Achram R, Arteaga‐Cortes L, Hendrickson J. Anti‐Fy3 in one hospital system: More common than expected. Transfusion 2025, 65: 1210-1211. PMID: 40390577, DOI: 10.1111/trf.18206.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
News
Copy Link
Get In Touch
Copy Link